To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

NCT03331523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

643

Enrollment

INDUSTRY

Sponsor class

Conditions

Scalp Psoriasis

Interventions

DRUG: Calcipotriene/Betamethasone Dipropionate
DRUG: Taclonex®
DRUG: Placebo

Sponsor

Glenmark Pharmaceuticals Ltd. India